Chemoinformaics analysis of Cetyl salicylate
| Molecular Weight | 362.554 | nRot | 16 |
| Heavy Atom Molecular Weight | 324.25 | nRig | 7 |
| Exact Molecular Weight | 362.282 | nRing | 1 |
| Solubility: LogS | -6.588 | nHRing | 0 |
| Solubility: LogP | 8.866 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 64 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 66.1541 |
| nHD | 1 | BPOL | 40.7259 |
| QED | 0.253 |
| Synth | 1.926 |
| Natural Product Likeliness | 0.054 |
| NR-PPAR-gamma | 0.555 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.16 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.981 |
| MDCK | 0.0000141 |
| BBB | 0.054 |
| PPB | 0.997679 |
| VDSS | 3.508 |
| FU | 0.00940713 |
| CYP1A2-inh | 0.236 |
| CYP1A2-sub | 0.175 |
| CYP2c19-inh | 0.545 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.116 |
| CYP2c9-sub | 0.969 |
| CYP2d6-inh | 0.583 |
| CYP2d6-sub | 0.074 |
| CYP3a4-inh | 0.314 |
| CYP3a4-sub | 0.054 |
| CL | 6.178 |
| T12 | 0.113 |
| hERG | 0.177 |
| Ames | 0.023 |
| ROA | 0.009 |
| SkinSen | 0.955 |
| Carcinogencity | 0.067 |
| EI | 0.985 |
| Respiratory | 0.284 |
| NR-Aromatase | 0.377 |
| Antiviral | Yes |
| Prediction | 0.639015 |